Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Palazestrant (OP-1250), A Complete Estrogen Receptor Antagonist, Inhibits Wild-type and Mutant ER-positive Breast Cancer Models as Monotherapy and in Combination.
Mol Cancer Ther. 2024 Mar 4;23(3):285-300. doi: 10.1158/1535-7163.MCT-23-0351.
Mol Cancer Ther. 2024.
PMID: 38102750
Free PMC article.
Mobilization of innate and adaptive antitumor immune responses by the RNP-targeting antibody ATRC-101.
Scholz A, DeFalco J, Leung Y, Aydin IT, Czupalla CJ, Cao W, Santos D, Vad N, Lippow SM, Baia G, Harbell M, Sapugay J, Zhang D, Wu DC, Wechsler E, Ye AZ, Wu JW, Peng X, Vivian J, Kaplan H, Collins R, Nguyen N, Whidden M, Kim D, Millward C, Benjamin J, Greenberg NM, Serafini TA, Emerling DE, Steinman L, Robinson WH, Manning-Bog A.
Scholz A, et al. Among authors: sapugay j.
Proc Natl Acad Sci U S A. 2022 May 10;119(19):e2123483119. doi: 10.1073/pnas.2123483119. Epub 2022 May 4.
Proc Natl Acad Sci U S A. 2022.
PMID: 35507878
Free PMC article.
Item in Clipboard
Cite
Cite